BioMed Innovations
This startup is ready for a serious funding conversation, not just a generic pitch.
Founder cases
Founder and seeker cases loaded from the database by backend SSR. Total public cards: 988.
This startup is ready for a serious funding conversation, not just a generic pitch.
We have tested the direction and now need funding to turn early traction into a stronger business. GenThera is pioneering advanced genetic therapies for rare diseases and is seeking $2,500,000 to accelerate product development an…
Looking for an investor who understands the market and can support practical growth. We are raising capital to advance our groundbreaking therapeutic methodologies that target cancer cells more effectively, enhancing patient outc…
Seeking investment for product delivery, hiring, sales and market expansion. We are raising capital to enhance our innovative cybersecurity platform that has already shown promising traction in securing enterprise networks.
We have tested the direction and now need funding to turn early traction into a stronger business.
i am building this project and looking for the right investor to help move it to the next stage.
The project is moving from planning to execution, and the next bottleneck is funding. 5 million to accelerate the development of our groundbreaking therapeutic platform aimed at treating chronic diseases.
This is a founder-led project looking for investment, operating support and long-term business discipline.
our team is opening a funding round for a project with clear demand and realistic execution steps. We need funding to accelerate development and expand our market reach.
the idea has moved beyond theory; now it needs capital, structure and commercial pressure. We are building a next-generation cybersecurity platform designed to protect small businesses from evolving online threats and are seeking…
We are preparing to scale this business carefully and need an investor who values execution over hype.
I am looking for a financial partner who can help turn this plan into a stable operating company. A cutting-edge biotech startup focused on developing personalized therapies for chronic diseases, seeking $1.5 million in investmen…